3.0.0 4158 2022-11-01T13:50:11Z 2022-11-01T13:50:11Z House HR 2019-08-02 116 [Congressional Record Volume 165, Number 132 (Friday, August 2, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. PINGREE:H.R. 4158.Congress has the power to enact this legislation pursuantto the following:Article I, Section VIII[Page H7489]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-08-05T16:02:16Z Referred to 2019-08-02T15:04:05Z CURE High Drug Prices Act 116 637 S 2019-02-28 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2019-08-05 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-08-02 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-08-02 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-08-02 Introduced in House IntroReferral 1000 9 Library of Congress P000597 Rep. Pingree, Chellie [D-ME-1] Chellie Pingree D ME 1 N Health Administrative remedies Civil actions and liability Health care costs and insurance Health care coverage and access Health programs administration and funding Inflation and prices Prescription drugs Health 00 2019-08-02 Introduced in House 2020-08-04T20:01:23Z Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act

This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.

]]> CURE High Drug Prices Act Display Title CURE High Drug Prices Act Official Title as Introduced To prohibit price gouging in the sale of drugs. Introduced in House IH Short Title(s) as Introduced CURE High Drug Prices Act Introduced in House IH Short Title(s) as Introduced Combatting Unreasonable Rises and Excessively High Drug Prices Act Introduced in House IH Introduced in House 2019-08-02T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr4158ih/xml/BILLS-116hr4158ih.xml 2019-08-05 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.